Ignite Creation Date:
2024-05-06 @ 9:00 AM
Last Modification Date:
2024-10-26 @ 12:08 PM
Study NCT ID:
NCT02873975
Status:
COMPLETED
Last Update Posted:
2022-10-21
First Post:
2016-08-17
Brief Title:
A Study of LY2606368 Prexasertib in Patients With Solid Tumors With Replicative Stress or Homologous Repair Deficiency
Sponsor:
Dana-Farber Cancer Institute
Organization:
Dana-Farber Cancer Institute
Organization Data
Organization:
Dana-Farber Cancer Institute
Class:
OTHER
Study ID:
16-281
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Dana-Farber Cancer Institute
Lead Sponsor Class:
OTHER
Responsible Party:
Geoffrey Shapiro MD PhD
Responsible Party Title:
Geoffrey Shapiro MD PhD
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Dana-Farber Cancer Institute
Old Name:
None
Old Organization:
None